Hilary Ann Wells, MD | |
19185 Sw 90th Ave, Kaiser Permanente Tualatin Medical Office, Tualatin, OR 97062-7558 | |
(503) 885-7300 | |
Not Available |
Full Name | Hilary Ann Wells |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 19185 Sw 90th Ave, Tualatin, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194830299 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD00041687 (Washington) | Secondary |
208000000X | Pediatrics | MD24132 (Oregon) | Primary |
Entity Name | Kaiser Foundation Health Plan Of The Northwest |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
University of Utah College of Nursing faculty member Kathie Supiano, MS, LCSW was recognized by Utah Business Magazine today as one of its 2009 Health Care Heroes. This annual recognition acknowledges excellence and innovation within the health care system and contributes to continuously improving the standard of care that Utah's organizations provide. The event took place at the Grand America Hotel located in downtown Salt Lake City.
DelMar Pharmaceuticals, Inc., today announced that it will be presenting new data related to the development of lead product candidate VAL-083 (dianhydrogalactitol) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, being held May 29-June 2, 2015, in Chicago, Illinois.
Highland Therapeutics Inc., a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success.
A new Johns Hopkins Medicine-led study provides the strongest evidence to date that hundreds of deceased donor kidneys, discarded each year after being deemed not suitable under current medical criteria, can be transplanted safely and effectively.
Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Hilary Ann Wells, MD 19185 Sw 90th Ave, Kaiser Permanente Tualatin Medical Office, Tualatin, OR 97062-7558 Ph: () - | Hilary Ann Wells, MD 19185 Sw 90th Ave, Kaiser Permanente Tualatin Medical Office, Tualatin, OR 97062-7558 Ph: (503) 885-7300 |
News Archive
University of Utah College of Nursing faculty member Kathie Supiano, MS, LCSW was recognized by Utah Business Magazine today as one of its 2009 Health Care Heroes. This annual recognition acknowledges excellence and innovation within the health care system and contributes to continuously improving the standard of care that Utah's organizations provide. The event took place at the Grand America Hotel located in downtown Salt Lake City.
DelMar Pharmaceuticals, Inc., today announced that it will be presenting new data related to the development of lead product candidate VAL-083 (dianhydrogalactitol) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, being held May 29-June 2, 2015, in Chicago, Illinois.
Highland Therapeutics Inc., a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success.
A new Johns Hopkins Medicine-led study provides the strongest evidence to date that hundreds of deceased donor kidneys, discarded each year after being deemed not suitable under current medical criteria, can be transplanted safely and effectively.
Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
Dr. Laura K Murphy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave Ste 340, Tualatin, OR 97062 Phone: 503-691-9777 Fax: 503-692-6736 | |
Kimberly Mersch Boyer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave Ste 340, Tualatin, OR 97062 Phone: 971-272-4650 Fax: 503-692-6736 | |
Julie A Fiene Yeager, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19260 Sw 65th Ave, Ste 340, Tualatin, OR 97062 Phone: 503-691-9777 Fax: 503-692-6736 | |
Magdalenne Marie Corso, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave, Ste 275, Tualatin, OR 97062 Phone: 503-691-2519 Fax: 503-659-8984 | |
Devin Corrigan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19260 Sw 65th Ave Ste 100, Tualatin, OR 97062 Phone: 503-691-2519 | |
Robin Rae Leslie, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19185 Sw 90th Ave, Tualatin, OR 97062 Phone: 503-885-7300 |